98%
921
2 minutes
20
This research introduces Oral Score Basic (OS-B), a novel Artificial Intelligence (AI) derived methodology designed to provide a comprehensive, objective assessment of individual teeth and overall oral health, initially focused on dental conditions. Leveraging data from more than 340,000 patients across 2,558 U.S. dental practices, OS-B combines radiographic findings and periodontal probing depths with a treatment probability-weighted cost function to quantify the severity of dental conditions. The OS-B score aims to address limitations in prior oral health scoring systems by incorporating nuanced clinical data accounting for disease severity, and providing a scalable, data-driven approach to measuring oral health. This score was developed using Overjet's FDA-cleared AI platform, which detects dental conditions using bitewing and periapical radiographs, providing a detailed analysis of each tooth. OS-B's effectiveness was validated by demonstrating a strong correlation between tooth scores and treatment costs, surpassing the predictive power of previous scoring systems. This research presents a foundational framework for AI-enabled oral health scoring, with potential applications in value-based care, population risk analysis, and consumer health management. Future iterations may expand to include additional dimensions of oral health beyond clinical conditions such as risk factors and measures of oral function and esthetics, further enhancing the score's public health and clinical utility and patient engagement.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12217982 | PMC |
http://dx.doi.org/10.1038/s41598-025-07484-7 | DOI Listing |
JAMA Psychiatry
September 2025
Denovo Biopharma LLC, San Diego, California.
Importance: This study represents a first successful use of a genetic biomarker to select potential responders in a prospective study in psychiatry. Liafensine, a triple reuptake inhibitor, may become a new precision medicine for treatment-resistant depression (TRD), a major unmet medical need.
Objective: To determine whether ANK3-positive patients with TRD benefit from a 1-mg and/or 2-mg daily oral dose of liafensine, compared with placebo, in a clinical trial.
Cult Health Sex
September 2025
Department of Behavioral and Social Sciences, Brown University, Providence, RI, USA.
Transgender women and sex workers in Brazil underutilise HIV prevention services. Understanding preferences and decision-making regarding HIV prevention can help develop new programmes to meet their needs. We conducted semi-structured interviews with 26 transgender women and travesti sex workers in São Paulo, Brazil.
View Article and Find Full Text PDFInt J Surg
September 2025
Department of Oral and Maxillofacial Surgery, The Affiliated Tai'an City Central Hospital of Qingdao University, Taian, China.
Cancer Causes Control
September 2025
College of Public Health, Iowa Cancer Registry, Epidemiology Department, University of Iowa, Iowa City, IA, USA.
Purpose: Human papillomavirus (HPV) causes oral and anogenital cancers, the incidence of which is increasing. Late-stage diagnosis is associated with increased mortality. Neighborhood-level characteristics and distance to place of diagnosis may impact timely diagnosis.
View Article and Find Full Text PDFCancer Causes Control
September 2025
Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA.
Purpose: The U.S. Preventive Services Task Force recommends that men aged 55-69 years undergo shared decision-making (SDM) regarding prostate cancer (PCa) screening, and routine screening is not recommended for older men or those with limited life expectancy.
View Article and Find Full Text PDF